The State of Texas Attorney General Files Lawsuit Against Acetaminophen Producers Over Autism Allegations

Judicial Proceedings
The Texas Attorney General, who supports former President Trump who is running for US Senate, accused the drug companies of concealing safety concerns of Tylenol

Texas Attorney General Ken Paxton is taking legal action against the makers of acetaminophen, alleging the corporations concealed potential risks that the pain reliever presented to children's neurological development.

The court filing follows thirty days after President Donald Trump promoted an unsubstantiated connection between taking acetaminophen - also known as acetaminophen - throughout gestation and autism in offspring.

Paxton is taking legal action against Johnson & Johnson, which once produced the drug, the sole analgesic approved for expectant mothers, and Kenvue, which presently makes it.

In a official comment, he stated they "deceived the public by gaining financially from pain and promoting medication without regard for the risks."

Kenvue states there is lacking scientific proof linking acetaminophen to autism.

"These companies lied for decades, intentionally threatening millions to increase profits," the attorney general, a Republican, declared.

The company stated officially that it was "deeply concerned by the spread of false claims on the security of acetaminophen and the possible consequences that could have on the welfare of American women and children."

On its online platform, Kenvue also stated it had "continuously evaluated the relevant science and there is lacking reliable evidence that shows a proven link between using acetaminophen and autism."

Associations acting on behalf of medical professionals and healthcare providers share this view.

The leading OB-GYN organization has declared paracetamol - the primary component in Tylenol - is a restricted selection for women during pregnancy to treat discomfort and elevated temperature, which can present serious health risks if not addressed.

"In multiple decades of investigation on the consumption of acetaminophen in pregnancy, zero credible investigations has definitively established that the consumption of acetaminophen in any stage of gestation results in brain development issues in children," the organization said.

The lawsuit mentions recent announcements from the previous government in asserting the medication is reportedly hazardous.

Recently, the former president raised alarms from health experts when he told pregnant women to "struggle intensely" not to take acetaminophen when sick.

The US Food and Drug Administration then published an announcement that medical professionals should contemplate reducing the usage of acetaminophen, while also mentioning that "a proven link" between the medication and autism in young ones has not been proven.

The Health Department head Robert F Kennedy Jr, who supervises the FDA, had promised in spring to undertake "a massive testing and research effort" that would determine the source of autism in a short period.

But authorities advised that identifying a sole reason of autism - considered by experts to be the consequence of a complicated interplay of genetic and surrounding conditions - would be difficult.

Autism is a form of enduring cognitive variation and condition that affects how persons perceive and engage with the world, and is identified using medical professional evaluations.

In his legal document, the attorney general - aligned with the former president who is campaigning for the Senate - alleges the manufacturer and Johnson & Johnson "intentionally overlooked and tried to quiet the evidence" around paracetamol and autism spectrum disorder.

This legal action seeks to make the firms "eliminate any marketing or advertising" that claims acetaminophen is safe for women during pregnancy.

The Texas lawsuit parallels the concerns of a assembly of mothers and fathers of children with autism spectrum disorder and attention deficit hyperactivity disorder who took legal action against the manufacturers of acetaminophen in 2022.

The court rejected the legal action, stating investigations from the plaintiffs' authorities was inconclusive.

Jill Price
Jill Price

A passionate vintage collector and stylist with over a decade of experience in curating retro fashion and decor.